These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 28425401)

  • 21. Screening for non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus using transient elastography.
    Lai LL; Wan Yusoff WNI; Vethakkan SR; Nik Mustapha NR; Mahadeva S; Chan WK
    J Gastroenterol Hepatol; 2019 Aug; 34(8):1396-1403. PubMed ID: 30551263
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prospective comparison of transient, point shear wave, and magnetic resonance elastography for staging liver fibrosis.
    Lefebvre T; Wartelle-Bladou C; Wong P; Sebastiani G; Giard JM; Castel H; Murphy-Lavallée J; Olivié D; Ilinca A; Sylvestre MP; Gilbert G; Gao ZH; Nguyen BN; Cloutier G; Tang A
    Eur Radiol; 2019 Dec; 29(12):6477-6488. PubMed ID: 31278577
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum cytokeratin-18 and its relation to liver fibrosis and steatosis diagnosed by FibroScan and controlled attenuation parameter in nonalcoholic fatty liver disease and hepatitis C virus patients.
    Darweesh SK; AbdElAziz RA; Abd-ElFatah DS; AbdElazim NA; Fathi SA; Attia D; AbdAllah M
    Eur J Gastroenterol Hepatol; 2019 May; 31(5):633-641. PubMed ID: 30839434
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of fibrosis during the development of fatty liver in rabbits using real-time shear-wave elastography.
    Lu YP; Wei J; Xu LR; Tang YY; Yuan Y; Zhang Y; Li YY
    J Huazhong Univ Sci Technolog Med Sci; 2014 Dec; 34(6):921-928. PubMed ID: 25480592
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Validation of magnetic resonance elastography plus fibrosis-4 for significant fibrosis in nonalcoholic fatty liver disease.
    Inada K; Tamaki N; Kurosaki M; Kirino S; Yamashita K; Hayakawa Y; Higuchi M; Takaura K; Kaneko S; Maeyashiki C; Yasui Y; Tsuchiya K; Nakanishi H; Izumi N
    J Gastroenterol Hepatol; 2022 Sep; 37(9):1726-1731. PubMed ID: 35587726
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic value of MR-based texture analysis for the assessment of hepatic fibrosis in patients with nonalcoholic fatty liver disease (NAFLD).
    Cannella R; Borhani AA; Tublin M; Behari J; Furlan A
    Abdom Radiol (NY); 2019 May; 44(5):1816-1824. PubMed ID: 30788556
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of Non-Alcoholic Fatty Liver Disease with Non-invasive Tools in Turkish People Living with HIV and with Apparently Normal Liver Function.
    Başaran NÇ; İdilman İ; Tokuçoğlu HA; Onur MR; Sönmezer MÇ; Özışık L; Karçaaltıncaba M; İnkaya AÇ; Ünal S
    Curr HIV Res; 2023; 21(3):192-201. PubMed ID: 37455457
    [TBL] [Abstract][Full Text] [Related]  

  • 28. American Gastroenterological Association Institute Technical Review on the Role of Elastography in Chronic Liver Diseases.
    Singh S; Muir AJ; Dieterich DT; Falck-Ytter YT
    Gastroenterology; 2017 May; 152(6):1544-1577. PubMed ID: 28442120
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased severity of liver fat content and liver fibrosis in non-alcoholic fatty liver disease correlate with epicardial fat volume in type 2 diabetes: A prospective study.
    Brouha SS; Nguyen P; Bettencourt R; Sirlin CB; Loomba R
    Eur Radiol; 2018 Apr; 28(4):1345-1355. PubMed ID: 29058029
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transient hepatic elastography has the best performance to evaluate liver fibrosis in non-alcoholic fatty liver disease (NAFLD).
    Tovo CV; Villela-Nogueira CA; Leite NC; Panke CL; Port GZ; Fernandes S; Buss C; Coral GP; Cardoso AC; Cravo CM; Calçado FL; Rezende GFM; Ferreira FC; Araujo-Neto JM; Perez RM; Moraes-Coelho HS; de Mattos AA
    Ann Hepatol; 2019; 18(3):445-449. PubMed ID: 31031166
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation and comparison of six noninvasive tests for prediction of significant or advanced fibrosis in nonalcoholic fatty liver disease.
    Staufer K; Halilbasic E; Spindelboeck W; Eilenberg M; Prager G; Stadlbauer V; Posch A; Munda P; Marculescu R; Obermayer-Pietsch B; Stift J; Lackner C; Trauner M; Stauber RE
    United European Gastroenterol J; 2019 Oct; 7(8):1113-1123. PubMed ID: 31662868
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel 3D Magnetic Resonance Elastography for the Noninvasive Diagnosis of Advanced Fibrosis in NAFLD: A Prospective Study.
    Loomba R; Cui J; Wolfson T; Haufe W; Hooker J; Szeverenyi N; Ang B; Bhatt A; Wang K; Aryafar H; Behling C; Valasek MA; Lin GY; Gamst A; Brenner DA; Yin M; Glaser KJ; Ehman RL; Sirlin CB
    Am J Gastroenterol; 2016 Jul; 111(7):986-94. PubMed ID: 27002798
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Magnetic resonance elastography measured shear stiffness as a biomarker of fibrosis in pediatric nonalcoholic fatty liver disease.
    Schwimmer JB; Behling C; Angeles JE; Paiz M; Durelle J; Africa J; Newton KP; Brunt EM; Lavine JE; Abrams SH; Masand P; Krishnamurthy R; Wong K; Ehman RL; Yin M; Glaser KJ; Dzyubak B; Wolfson T; Gamst AC; Hooker J; Haufe W; Schlein A; Hamilton G; Middleton MS; Sirlin CB
    Hepatology; 2017 Nov; 66(5):1474-1485. PubMed ID: 28493388
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.
    Eddowes PJ; Sasso M; Allison M; Tsochatzis E; Anstee QM; Sheridan D; Guha IN; Cobbold JF; Deeks JJ; Paradis V; Bedossa P; Newsome PN
    Gastroenterology; 2019 May; 156(6):1717-1730. PubMed ID: 30689971
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acoustic Radiation Force Impulse Elastography for the Non-Invasive Evaluation of Hepatic Fibrosis in Non-Alcoholic Fatty Liver Disease Patients: A Systematic Review & Meta-Analysis.
    Liu H; Fu J; Hong R; Liu L; Li F
    PLoS One; 2015; 10(7):e0127782. PubMed ID: 26131717
    [TBL] [Abstract][Full Text] [Related]  

  • 36. US Time-Harmonic Elastography: Detection of Liver Fibrosis in Adolescents with Extreme Obesity with Nonalcoholic Fatty Liver Disease.
    Hudert CA; Tzschätzsch H; Guo J; Rudolph B; Bläker H; Loddenkemper C; Luck W; Müller HP; Baumgart DC; Hamm B; Braun J; Holzhütter HG; Wiegand S; Sack I
    Radiology; 2018 Jul; 288(1):99-106. PubMed ID: 29762096
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Magnetic resonance elastography is superior to acoustic radiation force impulse for the Diagnosis of fibrosis in patients with biopsy-proven nonalcoholic fatty liver disease: A prospective study.
    Cui J; Heba E; Hernandez C; Haufe W; Hooker J; Andre MP; Valasek MA; Aryafar H; Sirlin CB; Loomba R
    Hepatology; 2016 Feb; 63(2):453-61. PubMed ID: 26560734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Editorial: Magnetic Resonance Elastography and Non-Alcoholic Fatty Liver Disease: Time for an Upgrade?
    Flores A; Asrani SK
    Am J Gastroenterol; 2016 Jul; 111(7):995-6. PubMed ID: 27356823
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Liver-specific diagnostic for non-alcoholic fatty liver disease (NAFLD) - time to replace liver biopsy?].
    Michel M; Schattenberg JM
    Z Gastroenterol; 2020 Dec; 58(12):1233-1240. PubMed ID: 33291177
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Shear Wave Elastography for Assessment of Steatohepatitis and Hepatic Fibrosis in Rat Models of Non-Alcoholic Fatty Liver Disease.
    Kang BK; Lee SS; Cheong H; Hong SM; Jang K; Lee MG
    Ultrasound Med Biol; 2015 Dec; 41(12):3205-15. PubMed ID: 26349582
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.